ストックスクリーナーアプリを入手
3.76
2.45%
0.09
アフターアワーズ：
3.75
-0.010
-0.27%
Oncology Institute Inc (TOI) 最新ニュース
Will earnings trigger a reversal in The Oncology Institute Inc. Equity WarrantTrade Entry Report & High Conviction Trade Alerts - Newser
Applying Wyckoff theory to The Oncology Institute Inc. stockJuly 2025 Fed Impact & Advanced Technical Analysis Signals - Newser
What moving averages say about The Oncology Institute Inc. Equity WarrantJuly 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Will breakout in The Oncology Institute Inc. Equity Warrant lead to full recovery - Newser
The Oncology Institute Inc. Equity Warrant stock volume spike explainedPortfolio Update Summary & High Conviction Buy Zone Alerts - Newser
Long term hold vs stop loss in The Oncology Institute Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Oncology Institute reaffirms FY25 revenue view $460M-$480M - MSN
The Oncology Institute shares fall 12.19% intraday despite strong Q2 revenue growth and new board leadership. - AInvest
The Oncology Institute Q2 Revenue Surges - AOL.com
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2025 Earnings Call Transcript - Insider Monkey
The Oncology Institute shares tumble 7% as earnings miss overshadows revenue beat - Investing.com Nigeria
The Oncology Institute stock rating reiterated at Buy by BTIG - Investing.com
How high can The Oncology Institute Inc. stock goEarnings Risk Report & Detailed Earnings Play Strategies - Newser
The Oncology Institute shares fall 1.22% premarket after announcing board changes and reporting Q2 earnings. - AInvest
Oncology Institute Sales Jump 22 Percent - AOL.com
Oncology Institute TOI Earnings Call Transcript - AOL.com
The Oncology Institute anticipates Q4 adjusted EBITDA positivity as pharmacy revenue grows 41% - MSN
Using AI based signals to follow The Oncology Institute Inc.2025 Dividend Review & Community Supported Trade Ideas - Newser
The Oncology Institute Reports Strong Q2 2025 Growth - TipRanks
Pattern recognition hints at The Oncology Institute Inc. upsideTake Profit & Capital Efficiency Focused Ideas - Newser
Oncology Institute earnings missed by $0.06, revenue topped estimates - Investing.com Canada
The Oncology Institute's Q2 2025: Navigating Contradictions in Drug Pricing, Revenue Growth, and Patient Volume - AInvest
Transcript : The Oncology Institute, Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
The Oncology Institute’s Revenue Jumps, Pharmacy Business Shines - Finimize
Oncology Institute Sales Jump 22 Percent - The Motley Fool
Earnings call transcript: Oncology Institute sees revenue rise in Q2 2025 - Investing.com Canada
Earnings call transcript: Oncology Institute sees revenue rise in Q2 2025 By Investing.com - Investing.com South Africa
Oncology Institute, Inc. SEC 10-Q Report - TradingView
Oncology Institute reports Q2 EPS (15c) vs. (17c) last year - TipRanks
Oncology Institute Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Oncology Institute Announces New Board Chairman - TipRanks
The Oncology Institute Reports 20% YoY Revenue Growth in Q2 2025. - AInvest
The Oncology Institute names Anne McGeorge as new chairman By Investing.com - Investing.com Canada
The Oncology Institute (TOIIW): Director Resigns; New Chair Named - Stock Titan
The Oncology Institute's Q2 revenue up 21.5%, beats estimates - MarketScreener
The Oncology Institute Announces Changes to Board of Directors - The Manila Times
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - GlobeNewswire
Press Release: The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - 富途牛牛
Former Grant Thornton Healthcare Leader Anne McGeorge Takes Chairman Role at The Oncology Institute - Stock Titan
Tools to assess The Oncology Institute Inc.’s risk profileJuly 2025 Recap & Accurate Buy Signal Notifications - Newser
Published on: 2025-08-13 06:40:28 - Newser
Can trapped investors hope for a rebound in The Oncology Institute Inc.Trade Exit Report & Technical Entry and Exit Alerts - Newser
Chartists See Breakout Potential in The Oncology Institute Inc. Equity WarrantJuly 2025 PostEarnings & Consistent Income Trade Ideas - 선데이타임즈
How to integrate The Oncology Institute Inc. Equity Warrant into portfolio analysis toolsQuarterly Growth Report & High Accuracy Investment Entry Signals - Newser
Using portfolio simulators with The Oncology Institute Inc. Equity Warrant included2025 Earnings Impact & Community Driven Trade Alerts - Newser
What technical models suggest about The Oncology Institute Inc. Equity Warrant’s comeback2025 Bull vs Bear & Stock Market Timing Techniques - Newser
Should you wait for a breakout in The Oncology Institute Inc.Stock Surge & Free Technical Confirmation Trade Alerts - Newser
The Oncology Institute Inc. stock prediction for this week2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
Historical volatility pattern of The Oncology Institute Inc. Equity Warrant visualizedForecast Model for Intraday Buy Signals - Newser
Published on: 2025-08-12 22:45:12 - beatles.ru
Has The Oncology Institute Inc. Equity Warrant found a price floorShort-Term Profit Alert With Entry Forecast - Newser
Published on: 2025-08-12 21:33:26 - 선데이타임즈
Comparing The Oncology Institute Inc. Equity Warrant in custom built stock radarsDaily Pick Forecast with Entry Zones - Newser
The Oncology Institute, Inc. shares fall 3.54% premarket after Pfizer and Astellas announce positive results for PADCEV™ and KEYTRUDA™ in bladder cancer trial. - AInvest
What earnings revisions data tells us about The Oncology Institute Inc. Equity WarrantBuy Signal Forecast With Short-Term Data - Newser
0.64%
0.28%
大文字化:
|
ボリューム (24 時間):